These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38281089)

  • 1. Oral anticoagulant safety in family practice: prognostic accuracy of Bleeding Risk Scores (from the CACAO study).
    Gaboreau Y; Frappé P; Vermorel C; Foote A; Bosson JL; Pernod G;
    Fam Pract; 2024 Feb; 41(1):9-17. PubMed ID: 38281089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
    Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB
    Am J Med; 2018 May; 131(5):574.e13-574.e27. PubMed ID: 29274754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
    Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study.
    Vedovati MC; Mancuso A; Pierpaoli L; Paliani U; Conti S; Ascani A; Galeotti G; Di Filippo F; Caponi C; Agnelli G; Becattini C
    Int J Cardiol; 2020 Feb; 301():167-172. PubMed ID: 31761402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulants' Safety and Effectiveness in General Practice: A Nationwide Prospective Cohort Study.
    Frappé P; Cogneau J; Gaboreau Y; Abenhaïm N; Bayen M; Guichard C; Jacquet JP; Lacoin F; Liébart S; Bertoletti L; Bosson JL;
    Ann Fam Med; 2020 Mar; 18(2):131-138. PubMed ID: 32152017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Gao X; Cai X; Yang Y; Zhou Y; Zhu W
    Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of Bleeding Risk Prediction Scores for Patients With Major Bleeding on Direct Oral Anticoagulants.
    Tchen S; Ryba N; Patel V; Cavanaugh J; Sullivan JB
    Ann Pharmacother; 2020 Dec; 54(12):1175-1184. PubMed ID: 32517484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants.
    Wattanaruengchai P; Nathisuwan S; Karaketklang K; Wongcharoen W; Phrommintikul A; Lip GYH
    Br J Clin Pharmacol; 2022 May; 88(5):2203-2212. PubMed ID: 34783372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
    Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.
    Beshir SA; Aziz Z; Yap LB; Chee KH; Lo YL
    J Clin Pharm Ther; 2018 Apr; 43(2):209-219. PubMed ID: 29030869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
    Roldán V; Marín F; Fernández H; Manzano-Fernandez S; Gallego P; Valdés M; Vicente V; Lip GYH
    Chest; 2013 Jan; 143(1):179-184. PubMed ID: 22722228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
    Makam RCP; Hoaglin DC; McManus DD; Wang V; Gore JM; Spencer FA; Pradhan R; Tran H; Yu H; Goldberg RJ
    PLoS One; 2018; 13(5):e0197583. PubMed ID: 29795629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
    Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P
    J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry).
    Mori N; Sotomi Y; Hirata A; Hirayama A; Sakata Y; Higuchi Y
    Am J Cardiol; 2019 Oct; 124(7):1044-1048. PubMed ID: 31353002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.